Hukyndra
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Hukyndra, covering 2026-01-28 to 2026-07-17. Get the full timeline:
Most recent: EMA Authorised: Hukyndra (adalimumab) — Stada Arzneimittel AG
2 regulatory and trial events tracked for Hukyndra, covering 2026-01-28 to 2026-07-17. Get the full timeline:
Most recent: EMA Authorised: Hukyndra (adalimumab) — Stada Arzneimittel AG